Back to Search
Start Over
Teva and Natco Announce Launch of additional strengths for the Generic Version of Revlimid[R] (lenalidomide capsules), in the U.S
- Source :
- Business Wire. March 9, 2023
- Publication Year :
- 2023
-
Abstract
- PARSIPPANY, N.J. & TEL AVIV, Israel & HYDERABAD, India -- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), and NATCO Pharma Limited (NSE: NATCOPHARM; [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Business Wire
- Publication Type :
- News
- Accession number :
- edsgcl.740204871